In March 2019, after a series of political convolutions worthy of a Choose Your Own Adventure novel, former UK Prime Minister Theresa May finally managed to bri 23 October 2019
In the runup to the annual meeting of the European Society of Medical Oncology (ESMO), one of the more eagerly anticipated presentations focused on former Loxo 4 October 2019
As the dust settles on 2019’s annual meeting of the European Society of Medical Oncology (ESMO), data from several candidates give hope that the burden of disea 4 October 2019
Pivotal data from a Phase II study of the FGFR inhibitor pemigatinib will be used to support a US filing later in the year, says Incyte chief executive Hervé Ho 27 September 2019
In Cambridge, USA, just around the corner from fellow gene therapy specialist Bluebird Bio, a less well-known biotech startup could be about to shake up the mar 24 September 2019
Investors in the Atlas Venture-backed immuno-oncology specialist Surface Oncology (Nasdaq: SURF) have had a rough time since the company went public in New York 5 September 2019
The UK’s Vaccines Manufacturing Innovation Centre (VMIC) is not due to open until 2022, but its first permanent chief executive has already been announced. 4 September 2019
UK-based Mundipharma is a unique player in healthcare, with Marco Cerato, its senior vice president, business development and strategic partnerships, telling Th 19 August 2019
Ensuring that the actions, messages and objectives of pharma companies and representative national and regional associations are aligned with the needs of patie 16 August 2019
Last year, Denmark-headquartered dermatology specialist LEO Pharma increased the size of its investment in R&D to 18%, compared to the 15% of the previous year. 25 July 2019
As the global medical lead of the Adcetris (brentuximab vedotin) program for Japanese pharma major Takeda, Thanos Zomas’ job was made easier by Phase III trial 22 July 2019
With marketing expenses stretching into the tens or even hundreds of millions of dollars, launching a new product can be a huge challenge for small pharmaceutic 12 July 2019
Europe's biggest privately-held biotech BioNTech has been in the news recently, with reports the company could be about to raise just shy of a billion dollars i 25 June 2019
For Belgium-based drugmaker UCB (Euronext: UCB), EULAR 2019 came at a good time to shed further new light on bimekizumab – which the company itself is billing a 21 June 2019
Marta Diez is the first woman president of Cámara de la Innovación Farmacéutica (CIF), a group representing 23 pharma multinationals with a presence in Chile. 12 June 2019
As the dust settles on this year’s annual meeting of the American Society of Clinical Oncology (ASCO), analysts have a lot of promising data to digest. 7 June 2019
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.